Comprehensive Bioinformatics Analysis of FXR1 Across Pan-cancer: Unraveling Its Diagnostic, Prognostic, and Immunological Significance

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2023 Dec 5

PMID 38050239

Authors

Keyuan Xiao

Ihsan Ullah

Fan Yang

Jiao Wang

Chunxia Hou

Yuqiang Liu

Xinghua Li

Affiliations

Soon will be listed here.

Abstract

Fragile X-related protein 1 (FXR1) is an RNA-binding protein that belongs to the fragile X-related (FXR) family. Studies have shown that FXR1 plays an important role in cancer cell proliferation, invasion and migration and is differentially expressed in cancers. This study aimed to gain a comprehensive and systematic understanding of the analysis of FXR1's role in cancers. This would lead to a better understanding of how it contributes to the development and progression of various malignancies. this study conducted through The Cancer Genome Atlas (TCGA), GTEx, cBioPortal, TISIDB, GEPIA2 and HPA databases to investigated FXR1's role in cancers. For data analysis, various software platforms and web platforms were used, such as R, Cytoscape, hiplot plateform. A significant difference in FXR1 expression was observed across molecular and immune subtypes and across types of cancer. FXR1 expression correlates with disease-specific survival (DSS), and overall survival (OS) in several cancer pathways, further in progression-free interval (PFI) in most cancers. Additionally, FXR1 showed a correlation with genetic markers of immunomodulators in different cancer types. Our study provides insights into the role of FXR1 in promoting, inhibiting, and treating diverse cancers. FXR1 has the potential to serve as a diagnostic and prognostic biomarker for cancer, with therapeutic value in immune-based, targeted, or cytotoxic treatments. Further clinical validation and exploration of FXR1 in cancer treatment is necessary.

References

Nichols N, Bras J, Hernandez D, Jansen I, Lesage S, Lubbe S . EIF4G1 mutations do not cause Parkinson's disease. Neurobiol Aging. 2015; 36(8):2444.e1-4. PMC: 4464946. DOI: 10.1016/j.neurobiolaging.2015.04.017. View

Deng M, Wang N, Li Z, Chen R, Duan J, Peng Y . FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA. Cell Death Dis. 2022; 13(2):170. PMC: 8863821. DOI: 10.1038/s41419-022-04614-1. View

Eder S, Arndt A, Lamkowski A, Daskalaki W, Rump A, Priller M . Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K). Cancer Lett. 2016; 385:160-167. DOI: 10.1016/j.canlet.2016.10.027. View

Hinnebusch A . The scanning mechanism of eukaryotic translation initiation. Annu Rev Biochem. 2014; 83:779-812. DOI: 10.1146/annurev-biochem-060713-035802. View

Qie S, Majumder M, Mackiewicz K, Howley B, Peterson Y, Howe P . Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma. Nat Commun. 2017; 8(1):1534. PMC: 5688124. DOI: 10.1038/s41467-017-01199-8. View

Huttenlocher J, Kruger R, Capetian P, Lohmann K, Brockmann K, Csoti I . EIF4G1 is neither a strong nor a common risk factor for Parkinson's disease: evidence from large European cohorts. J Med Genet. 2014; 52(1):37-41. DOI: 10.1136/jmedgenet-2014-102570. View

Gao H, Sun J, Wang Y, Lu Y, Liu L, Zhao Q . Predicting metabolite-disease associations based on auto-encoder and non-negative matrix factorization. Brief Bioinform. 2023; 24(5). DOI: 10.1093/bib/bbad259. View

Li Y, Zhao X . Concise review: Fragile X proteins in stem cell maintenance and differentiation. Stem Cells. 2014; 32(7):1724-33. PMC: 4255947. DOI: 10.1002/stem.1698. View

Bu H, Cao T, Li X, Guo Y, Guo J, Wang Y . Diagnostic and prognostic potential of the novel biomarker nuclear cap binding protein subunit 2 () in colon adenocarcinoma. J Gastrointest Oncol. 2022; 13(4):1782-1792. PMC: 9459195. DOI: 10.21037/jgo-22-665. View

10.

Chakraborty P, Grosse F . Human DHX9 helicase preferentially unwinds RNA-containing displacement loops (R-loops) and G-quadruplexes. DNA Repair (Amst). 2011; 10(6):654-65. DOI: 10.1016/j.dnarep.2011.04.013. View

11.

Chen X, Gu P, Xie R, Han J, Liu H, Wang B . Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer. J Cell Mol Med. 2016; 21(7):1266-1279. PMC: 5487918. DOI: 10.1111/jcmm.12999. View

12.

Jin X, Zhai B, Fang T, Guo X, Xu L . FXR1 is elevated in colorectal cancer and acts as an oncogene. Tumour Biol. 2015; 37(2):2683-90. DOI: 10.1007/s13277-015-4068-9. View

13.

Chua M, Ortega C, Sheikh A, Lee M, Abdul-Rassoul H, Hartshorn K . CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target. Pharmaceuticals (Basel). 2017; 10(1). PMC: 5374422. DOI: 10.3390/ph10010018. View

14.

Cristini A, Groh M, Kristiansen M, Gromak N . RNA/DNA Hybrid Interactome Identifies DXH9 as a Molecular Player in Transcriptional Termination and R-Loop-Associated DNA Damage. Cell Rep. 2018; 23(6):1891-1905. PMC: 5976580. DOI: 10.1016/j.celrep.2018.04.025. View

15.

Yang J, Chiou Y, Fu S, Shih I, Weng T, Lin W . Arginine methylation of hnRNPK negatively modulates apoptosis upon DNA damage through local regulation of phosphorylation. Nucleic Acids Res. 2014; 42(15):9908-24. PMC: 4150800. DOI: 10.1093/nar/gku705. View

16.

Lin X, Xiao M, Chen Z, Ding C, Zhang T, Li Q . Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors. J Oncol. 2022; 2022:6115878. PMC: 9152430. DOI: 10.1155/2022/6115878. View

17.

Wang T, Sun J, Zhao Q . Investigating cardiotoxicity related with hERG channel blockers using molecular fingerprints and graph attention mechanism. Comput Biol Med. 2022; 153:106464. DOI: 10.1016/j.compbiomed.2022.106464. View

18.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

19.

Nakanishi K, Ozeki N, Tateyama H, Kadomatsu Y, Ueno H, Goto M . Skeletal muscle and related protein expression as prognostic factors in thymic squamous cell carcinoma. J Thorac Dis. 2022; 14(9):3245-3254. PMC: 9562531. DOI: 10.21037/jtd-22-385. View

20.

Jain A, Bacolla A, Del Mundo I, Zhao J, Wang G, Vasquez K . DHX9 helicase is involved in preventing genomic instability induced by alternatively structured DNA in human cells. Nucleic Acids Res. 2013; 41(22):10345-57. PMC: 3905860. DOI: 10.1093/nar/gkt804. View